Condition
Premature Ventricular Contraction (PVC) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Premature Ventricular Contraction (PVC) clinical trials that are recruiting, at sites in 3 countries (most in United States (2), Greece (1), Australia (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Premature Ventricular Contraction (PVC) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Catheter ablation vs. anti-arrhythmic drugs for PVCs | — | Westmead, New South Wales | Recruiting | Mar 3, 2026 |
| Disrupted sleep and irregular heartbeats in people with hypoglossal nerve stimulators | — | San Francisco, California | Recruiting | Oct 24, 2025 |
| Using flecainide to treat frequent premature ventricular contractions and related heart issues | — | Pátrai, Achaia and 5 other locations | Recruiting | Apr 29, 2025 |
| Using adenosine to understand the causes of premature ventricular contractions | Phase 4 | New York, New York | Recruiting | Jul 14, 2017 |
All recruiting trials (4)
-
Catheter ablation vs. anti-arrhythmic drugs for PVCs
This study tests whether catheter ablation or anti-arrhythmic medications are better at reducing PVC symptoms and improving quality of life for adults with a normal heart function.
-
Disrupted sleep and irregular heartbeats in people with hypoglossal nerve stimulators
This study will test whether turning a hypoglossal nerve stimulation (HGNS) device off for a night increases the chance of irregular heartbeats or short atrial fibrillation episodes in adults with obstructive sleep apnea who already have an HGNS implant.
-
Using flecainide to treat frequent premature ventricular contractions and related heart issues
This study is testing if the heart medication flecainide can help adults with frequent heartbeats and related heart issues who can't or don't want to have a procedure called catheter ablation.
-
Using adenosine to understand the causes of premature ventricular contractions
This study is testing if giving adenosine and verapamil to patients can help doctors understand what causes premature ventricular contractions (PVCs) and how to better treat them.
Related topics
Quick answers
How many Premature Ventricular Contraction (PVC) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Greece (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.